🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Considerable progress in the treatment of metastatic melanoma has been made...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2015-10
Trial ID
NCT02619058
Treatments Being Tested
The purpose of this phase II clinical study is to test the good and bad eff...
Status
Completed
Location
Memorial Sloan Kettering Monmouth
Start Date
2016-06-21
Trial ID
NCT02819843
Treatments Being Tested
This study assesses efficacy of scalp block and Ultrasound guided transvers...
Status
Completed
Location
Yashoda Hospitals
Start Date
2017-07-15
Trial ID
NCT03667352
Treatments Being Tested
This is a multicenter, safety and pharmacokinetic trial to determine the MT...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2014-04-29
Trial ID
NCT01748149
Treatments Being Tested
Despite advances in medications, allergic diseases, including allergic asth...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2013-01
Trial ID
NCT01711593
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Status
Unknown
Location
Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital
Start Date
2015-10
Trial ID
NCT02580747
Treatments Being Tested
Background: * PSA (prostate specific antigen) is a protein found on normal...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2009-05-11
Trial ID
NCT00972309
RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Status
Completed
Location
Knight Cancer Institute at Oregon Health and Science University
Start Date
2005-03
Trial ID
NCT00238433
The primary purpose of this Phase 1 study is to evaluate the safety, tolera...
Status
Terminated
Location
University of California, San Francisco
Start Date
2015-08-27
Trial ID
NCT02428309
Treatments Being Tested